Skip to content

DMT: all studies

Page 88 of 160: studies 871 to 880 of 1,593, newest first. Back to the DMT overview

Research

Psychedelics in neuroinflammation: Mechanisms and therapeutic potential

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 31, 2025 Júnia L. de Deus, Juliana Marino Maia, Renato Nery Soriano et al. 27 citations

Neuroinflammation is a critical factor in the pathogenesis of various neurodegenerative and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and major depressive disorder. Psychedelics, such as psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT), have demonstrated promising therapeutic effects on neuroinflammation, primarily through interactions...

Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users’ Patterns of Use and Perceived Effects

Journal of Psychoactive Drugs January 29, 2025 Carrie Cuttler, Amanda Stueber, Jonathan J. Simone et al. 3 citations

The ever-changing landscape surrounding legality and accessibility of psychedelics and their increasing popularity make it imperative to better understand the nature of psychedelic use by the general population. To this end, 1,486 eligible respondents (Mage = 29.58, 67.1% male) residing in the United States completed an online survey designed to assess the types of psychedelics used, methods of...

DOI: 10.1080/02791072.2025.2452226 (opens in new tab) Acute effects Administration methods Intentions Psychedelics +4

Yopo (Anadenanthera peregrina (L.) Speg. Fabaceae)

January 23, 2025 Noureddine Chaachouay, Allal Douira, Lahcen Zidane

Anadenanthera peregrina (L.) Speg., sometimes called Cohoba or Yopo, is a plant species that falls under the scientific classification of the Fabaceae family under the Fabales order in the plant kingdom. It belongs to the Anadenanthera genus. This woody plant may grow to a height of 27 meters, forming various shapes, from small shrubs to massive trees. Anadenanthera peregrina (L.) Speg....

DOI: 10.1201/9781003460336-19 (opens in new tab) Fabaceae Botany Bioactive natural compounds Rabbits

Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022).

Progress in Neuro-Psychopharmacology and Biological Psychiatry January 10, 2025 Emma I Kopra, Jenni Penttinen, James J Rucker et al. 9 citations

Psychedelic drugs are increasingly visible in society once more, but their risks and adverse effects have received less attention than perhaps they should. While fatalities associated with psychedelics appear rare, a systematic approach to characterising their aetiology is required to inform harm minimisation efforts. This study aimed to analyse prevalence and characteristics of...

DOI: 10.1016/j.pnpbp.2024.111177 (opens in new tab) Full text (opens in new tab) Psychedelics hallucinogens Entheogens Psychedelic drugs Pharmaceutical safety +7

Structural insights into tryptamine psychedelics: The role of hydroxyl indole ring site in 5-HT2A receptor activation and psychedelic-like activity.

European journal of medicinal chemistry January 5, 2025 Miyuan Zhang, Yuefeng Yang, Zhishuai Yang et al. 10 citations

Recent advancements in the study of mushroom-derived tryptamines, particularly psilocybin and its metabolite psilocin, highlight their unique psychedelic properties and potential therapeutic applications, especially for mental health conditions like depression. This study examines how the position of the hydroxyl group on the indole ring affects the 5-HT2A receptor activity and psychedelic-like...

Evaluation of the carcinogenic potential of ayahuasca employing the epithelial tumor test in Drosophila melanogaster

Open Access Journal of Science 2025 Alexandre Azenha Alves de Rezende, Luis Felipe Dos Santos Silva, Luciana Karen Calábria

Ayahuasca is a psychoactive drink used mainly by indigenous peoples. Its preparation involves the decoction of the Banisteriopsis caapi (Spruce ex Griseb.) C.V. Morton vine with Psychotria viridis Ruiz & Pav. leaves. The psychoactive effect is derived from the combination of the dimethyltryptamine from the shrub with the alkaloids from the vine. Given the promising therapeutic potential and the...

The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research

Repository for Publications and Research Data 2025 Kurt Stocker, Matthias Hartmann, Yasmin Schmid et al.

Background: The Altered States of Consciousness Scale (3/5D-ASC or 11-ASC) is widely used to assess non-ordinary states of consciousness, particularly for psychedelic research. However, its original dimensional model (3D-ASC within 5D-ASC) and later 11-subscale structure (11-ASC) have a hierarchically incompatible higher/lower-order structure. Although the 11-ASC offers superior model fit, the...

DOI: 10.3929/ethz-c-000791180 (opens in new tab) Anxiety Revalidation Confirmatory factor analysis Rating scale +20

The effects of psychedelics on neuroplasticity: A review of current research and the possibility of therapeutic application in psychiatry

Engrami 2025 Mile Jevtić 1 citation

Psychedelics are psychoactive substances that cause changes in perception, state of consciousness, mood and numerous cognitive processes. The best known are lysergic acid diethylamide (LSD), N,N-dimethyltryptamine (DMT), psilocybin and mescaline. The main mechanism of action of psychedelics is agonism towards serotonin 5-HT2A receptors. In the middle of the 20th century, interest in the use of...

Expressive resource in a clinical psychedelic study: Art as an integration tool.

Progress in Brain Research 2025 Handersson Barros, Marcelo Falchi-Carvalho, Lucas O. Maia et al. 2 citations

Psychedelic experiences, especially those induced by substances such as N,N-Dimethyltryptamine (DMT), are often characterized by high subjective intensity, complex visual content, and notable ineffability-that is, the difficulty of being fully expressed in words. This expressive limitation poses a significant challenge to the integration of the experience, which is essential for the therapeutic...

DOI: 10.1016/bs.pbr.2025.07.004 (opens in new tab) Full text (opens in new tab) Clinical trials Expressive resource Mandala N,N-Dimethyltryptamine DMT +2

Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics

Current Topics in Behavioral Neurosciences 2025 Tim Hirschfeld, Felix Blei, Lavinia Stegemann et al. 1 citation

Classic psychedelics such as LSD, psilocybin, and DMT from unregulated markets pose considerable risks through unknown adulterants and potencies. In this chapter, we explore the importance of drug checking in minimizing harm among users of classic psychedelics and examine the opportunities and challenges associated with intervention settings, analytical techniques, and risk communication...